Samantha McLemore - Patient Capital Management
Holding/activity history for Precigen Inc. (PGEN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 17,937,694 | 0.83 | Reduce 1.30% | 0.01 | $0.95 |
| 2024 Q2 | 18,174,658 | 1.53 | Add 4.13% | 0.06 | $1.58 |
| 2024 Q1 | 17,453,455 | 1.23 | Add 9.20% | 0.10 | $1.45 |
| 2023 Q4 | 15,983,700 | 1.14 | Add 16.22% | 0.16 | $1.34 |
| 2023 Q3 | 13,753,176 | 1.15 | Add 22.32% | 0.21 | $1.42 |
| 2023 Q2 | 11,243,560 | 0.72 | Add 668.13% | 0.63 | $1.15 |
| 2023 Q1 | 1,463,760 | 0.70 | Add 83.38% | 0.32 | $1.06 |
| 2022 Q4 | 798,200 | 0.60 | Add 167.67% | 0.38 | $1.52 |
| 2022 Q3 | 298,200 | 0.32 | $2.12 | ||
| 2022 Q2 | 298,200 | 0.20 | $1.34 | ||
| 2022 Q1 | 298,200 | 0.25 | $2.11 | ||
| 2021 Q4 | 298,200 | 0.45 | $3.71 |